Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGASYS) Therapy Renders High Clinical and Molecular Response Rates in Patients with Essential Thrombocythemia (ET) and Polycythemia VERA (PV)

被引：0
|
作者：
Quintas-Cardania, Alfonso [1 ]
Kantarjian, Hagop M. [1 ]
Garcia-Manero, Guillermo [1 ]
Cortes, Jorge [1 ]
Richie, Marie Ann [1 ]
Borthakur, Gautam [1 ]
Verstovsek, Srdan [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：246 / 246
页数：1
相关论文
共 38 条
  • [1] Pegylated interferon-alfa-2a (PEG-IFN-α-2A; PEGASYSTM) for essential thrombocythemia (ET) and polycythemia vera (PV):: An update of an ongoing phase II study
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Richie, Marie Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2007, 110 (11) : 1036A - 1037A
  • [2] Dynamics of Mutant Alleles in Patients with Advanced Essential Thrombocythernia (ET) or Polycythemia (PV) During Pegylated Interferon-Alfa-2A (PEG-IFN-α-2A; Pegasys) Therapy
    Quintas-Cardama, Alfonso
    Abdel-Wahab, Omar
    Levine, Ross L.
    Manshouri, Taghi
    Roupie, Anne-Laure
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    [J]. BLOOD, 2011, 118 (21) : 130 - 130
  • [3] Treatment with pegylated Interferon-Atfa-2A (PEG-IFN-Aα-2A; PEGASYS™) for patients with essential thrombocythemia (ET) and polycythemia vera (PV).
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Giles, Francis
    Cortes, Jorge
    Richie, Mary Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2006, 108 (11) : 307B - 307B
  • [4] High Rates of Molecular Response After Long-Term Follow-up of Patients with Advanced Essential Thrombocythemia (ET) or Polycythemia Vera (PV) Treated With Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGA-SYS)
    Quintas-Cardama, Alfonso
    Levine, Ross
    Manshouri, Taghi
    Kilpivaara, Outi
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    [J]. BLOOD, 2010, 116 (21) : 206 - 206
  • [5] Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
    Masarova, Lucia
    Yin, C. Cameron
    Cortes, Jorge E.
    Konopleva, Marina
    Borthakur, Gautam
    Newberry, Kate J.
    Kantarjian, Hagop M.
    Bueso-Ramos, Carlos E.
    Verstovsek, Srdan
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [6] Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
    Lucia Masarova
    C. Cameron Yin
    Jorge E. Cortes
    Marina Konopleva
    Gautam Borthakur
    Kate J. Newberry
    Hagop M. Kantarjian
    Carlos E. Bueso-Ramos
    Srdan Verstovsek
    [J]. Experimental Hematology & Oncology, 6
  • [7] Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Manshouri, Taghi
    Luthra, Rajyalakshmi
    Estrov, Zeev
    Pierce, Sherry
    Richie, Mary Ann
    Borthakur, Gautam
    Konopleva, Marina
    Cortes, Jorge
    Verstovsek, Srdan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (32) : 5418 - 5424
  • [8] Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a
    Quintas-Cardama, Alfonso
    Abdel-Wahab, Omar
    Manshouri, Taghi
    Kilpivaara, Outi
    Cortes, Jorge
    Roupie, Anne-Laure
    Zhang, Su-Jiang
    Harris, David
    Estrov, Zeev
    Kantarjian, Hagop
    Levine, Ross L.
    Verstovsek, Srdan
    [J]. BLOOD, 2013, 122 (06) : 893 - 901
  • [9] Compassionate Use of Ropeginterferon-Alfa-2b/P1101 for Treatment of High Risk Polycythemia Vera and Essential Thrombocythemia Patients Previously Controlled on Pegylated Interferon-Alfa-2a/Pegasys®
    Gilreath, Jeffrey A.
    Tashi, Tsewang
    Kim, Soo Jin
    Hickman, Kimberly
    Prchal, Josef T.
    [J]. BLOOD, 2018, 132
  • [10] Histomorphological Responses after Therapy with Pegylated Interferon Alpha-2a in Patients with Essential Thrombocythemia (ET) and Polycythemia Vera (PV)
    Masarova, Lucia
    Yin, C. Cameron
    Cortes, Jorge E.
    Konopleva, Marina
    Borthakur, Gautam
    Newberry, Kate J.
    Kantarjian, Hagop M.
    Bueso-Ramos, Carlos E.
    Verstovsek, Srdan
    [J]. BLOOD, 2016, 128 (22)
1234